SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities

SET8 is implicated in transcriptional regulation, heterochromatin formation, genomic stability, cell‐cycle progression, and development. As such, it is predicted that SET8 might be involved in the development and progression of tumour. However, whether and how SET8 might be implicated in tumourigenesis is currently unknown. Here, we report that SET8 is physically associated with TWIST, a master regulator of epithelial–mesenchymal transition (EMT). We demonstrated that SET8 and TWIST are functionally interdependent in promoting EMT and enhancing the invasive potential of breast cancer cells in vitro and in vivo . We showed that SET8 acts as a dual epigenetic modifier on the promoters of the TWIST target genes E‐cadherin and N‐cadherin via its H4K20 monomethylation activity. Significantly, in breast carcinoma samples, SET8 expression is positively correlated with metastasis and the expression of TWIST and N‐cadherin and negatively correlated with E‐cadherin . Together, our experiments revealed a novel role for SET8 in tumour invasion and metastasis and provide a molecular mechanism underlying TWIST‐promoted EMT, suggesting SET8 as a potential target for intervention of the metastasis of breast cancer. The histone H4 methyltransferase SET8 is a novel transcriptional co‐regulator for the transcription factor Twist, promoting epithelial–mesenchymal transition. Mouse in vivo studies and co‐expression data in human metastatic breast cancers reveal that Set8 is involved in Twist‐associated tumour metastization.